Drug profile · INN
mavorixafor
XOLREMDI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
mavorixafor (XOLREMDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN mavorixafor
Brand XOLREMDI
Route ORAL
Formulation CAPSULE
ATC code L03AX24
Frequently asked questions
What is mavorixafor?
mavorixafor (XOLREMDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mavorixafor?
XOLREMDI is a marketed brand name for mavorixafor. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mavorixafor?
mavorixafor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.